MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Cancer Research

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11156211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alu‐associated interstitial deletions and chromosomal re‐arrangement in 2 human multidrug‐resistant cell lines

  2000cited by this paper
• Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands

  1999cited by this paper
• Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.

  1999cited by this paper
• Is nuclear expression of Y box‐binding protein‐1 a new prognostic factor in ovarian serous adenocarcinoma?

  1999cited by this paper
• Multidrug resistance-associated protein subfamily transporters and drug resistance.

  1999cited by this paper
• Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene*

  1998cited by this paper
• Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP

  1998cited by this paper
• Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias.

  1998cited by this paper
• An Alternative Promoter in the Mouse Major Histocompatibility Complex Class II I-Aβ Gene: Implications for the Origin of CpG Islands

  1998cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone

  1998cited by this paper
• Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.

  1998cited by this paper
• Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer.

  1997cited by this paper
• How does DNA methylation repress transcription?

  1997cited by this paper
• Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation*

  1997cited by this paper
• Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.

  1997cited by this paper
• Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

  1997cited by this paper
• Maintenance of hypomethylation status and preferential expression of exogenous humanMDR1/PGY1 gene in mouse L cells by YAC mediated transfer

  1997cited by this paper
• Gene rearrangement: a novel mechanism for MDR-1 gene activation.

  1997cited by this paper
• Establishment and characterization of two human bladder cancer cell lines.

  1996cited by this paper
• Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

  1996cited by this paper
• Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.

  1995cited by this paper
• Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.

  1995cited by this paper
• Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.

  1995cited by this paper
• Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.

  1994cited by this paper
• Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.

  1994cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Evaluation of multiple drug resistance in human bladder cancer cell lines.

  1993cited by this paper
• Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.

  1992cited by this paper
• Expression of the Multidrug Resistance Gene in Human Cancer

  1991cited by this paper
• Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.

  1990cited by this paper
• Expression of Multidrug Resistance Gene in Human Cancers

  1989cited by this paper
• Mechanism of multidrug resistance.

  1988cited by this paper
• Genes amplified and overexpressed in human multidrug-resistant cell lines.

  1988cited by this paper
• Expression of a multidrug-resistance gene in human tumors and tissues.

  1987cited by this paper
• BMDP program for piecewise linear regression.

  1986cited by this paper
• Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

  1983cited by this paper
• DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression

  1982cited by this paper

• Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer

  2025cites this paper
• The Role of Epigenetic Factors in Cancer Drug Resistance

  2025influential citation
• Updates on altered signaling pathways in tumor drug resistance

  2024cites this paper
• Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer.

  2023cites this paper
• Advanced oxidation protein products upregulate ABCB1 expression and activity via HDAC2-Foxo3α-mediated signaling in vitro and in vivo.

  2022cites this paper
• Epigenetic Regulation Towards Acquired Drug Resistance in Cancer.

  2022cites this paper
• [Role of ABC Transporters in Cancer Development and Malignant Alteration].

  2022cites this paper
• Tepoxalin increases chemotherapy efficacy in drug-resistant breast cancer cells overexpressing the multidrug transporter gene ABCB1

  2021cites this paper
• Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer

  2021cites this paper
• Therapeutic Targets and Predictive Markers of Treatment Efficacy of Bladder Cancer

  2020cites this paper
• The effects of anthracycline drugs on the conformational distribution of mouse P-glycoprotein explains their transport rate differences.

  2020cites this paper
• A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation.

  2020cites this paper
• Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution.

  2020cites this paper
• Efflux transporters in cancer resistance: Molecular and functional characterization of P-glycoprotein

  2020cites this paper
• Aberrant DNA Methylation of ABC Transporters in Cancer

  2020cites this paper
• Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport

  2019cites this paper
• Intercellular transfer of P-glycoprotein mediates the formation of stable multi-drug resistance in human bladder cancer BIU-87 cells

  2019cites this paper
• Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet

  2019cites this paper
• Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer

  2018cites this paper
• Structure and Function of Multidrug Resistance Protein 1

  2018cites this paper
• Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic Opportunities.

  2018cites this paper
• Role of epigenome in tumorigenesis and drug resistance.

  2017cites this paper
• Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway

  2017cites this paper
• Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.

  2017cites this paper
• Pitfalls and Opportunities for Epigenomic Analyses Focused on Disease Diagnosis, Prognosis, and Therapy.

  2017cites this paper
• The Role of Astrocyte-Derived Factors in the Regulation of Multidrug Resistance at the Developing Blood-Brain Barrier

  2016cites this paper
• Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery

  2016cites this paper
• Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder

  2016cites this paper
• Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment

  2016cites this paper
• DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically

  2016cites this paper
• Inhibition of the EGFR / STAT 3 / CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder

  2016cites this paper
• Epigenetic Control of Genes Involved in Cancer Initiation and Progression

  2016cites this paper
• ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview

  2016cites this paper
• Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity

  2015cites this paper
• Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma

  2015cites this paper
• Non-genetic resistant mechanism to EGFR tyrosine kinase inhibitory therapy

  2015cites this paper
• Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing

  2015cites this paper
• P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases

  2015cites this paper
• The Alterations in the Expression and Function of P-Glycoprotein in Vitamin A-Deficient Rats as well as the Effect of Drug Disposition in Vivo

  2015cites this paper
• Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation

  2015cites this paper
• Drugs Affecting Epigenetic Modifications of ABC Transporters for Drug Resistance

  2015cites this paper
• DNA Methylation in Acquired Drug Resistance

  2015cites this paper
• Mechanisms of P-glycoprotein alteration during anticancer treatment: role in the pharmacokinetic and pharmacological effects of various substrate drugs.

  2014cites this paper
• Epigenetics and Oncology

  2014cites this paper
• 抗がん剤治療時における P-glycoproteinの発現・機能変動と薬物動態並びに薬理作用へ及ぼす影響

  2014cites this paper
• Epigenetic Changes in Gene Expression for Drug‐Metabolizing Enzymes and Transporters

  2014cites this paper
• Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.

  2014cites this paper
• Evaluation of DNA methylation profiles of the CpG island of the ABCB1 gene in dogs with lymphoma.

  2014cites this paper
• Intercellular transfer of P-glycoprotein from the drug resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact.

  2013cites this paper
• Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis

  2013cites this paper
• Inactivate the two-faced HDAC-brake: Cell cycle regulation and tumor suppression by histone deacetylases HDAC1 and HDAC2

  2013cites this paper
• Progress in Personalizing Chemotherapy for Bladder Cancer

  2012cites this paper
• Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese Population

  2012cites this paper
• Molecular Pathways Molecular Pathways : Regulation and Therapeutic Implications of Multidrug Resistance

  2012cites this paper
• Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.

  2012cites this paper
• New therapeutic challenges in advanced bladder cancer.

  2012cites this paper
• DNA Methylation Patterns in Cancer

  2012cites this paper
• Epigenetic Biomarkers in Bladder Cancer

  2012cites this paper
• Quantitative analysis of multiple gene promoter methylation in Korean non-small cell lung cancer patients and its association study with cancer risk factor and survival

  2012cites this paper
• Metastatic bladder cancer: anything new?

  2012cites this paper
• Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats

  2011cites this paper
• Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model.

  2011cites this paper
• Decreased expression of intestinal P-glycoprotein increases the analgesic effects of oral morphine in a streptozotocin-induced diabetic mouse model.

  2011cites this paper
• Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

  2011cites this paper
• Ectonucleoside triphosphate diphosphohydrolase 6 expression in testis and testicular cancer and its implication in cisplatin resistance.

  2011cites this paper
• Regulatory action of nitric oxide synthase on ileal P-glycoprotein expression under streptozotocin-induced diabetic condition.

  2011cites this paper
• DNA Methylation Profiles of Organic Anion Transporting Polypeptide 1B3 in Cancer Cell Lines

  2010cites this paper
• Overcoming drug resistance by regulating nuclear receptors.

  2010cites this paper
• Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

  2010cites this paper
• The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance

  2010cites this paper
• Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions.

  2010cites this paper
• Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

  2010cites this paper
• Synthesis, characterization, and molecular structure of a novel zinc (II) complex: assessment of impact of MDR1Pgp expression on its cytotoxic activity.

  2010cites this paper
• Sensitivity of doxorubicin-resistant cells to sorafenib: possible role for inhibition of eukaryotic initiation factor-2alpha phosphorylation.

  2010cites this paper
• Promoter Methylation Status of Multidrug Resistance 1 (MDR1) Gene in Noncancerous Gastric Mucosa Correlates With Helicobacter Pylori Infection and Gastric Cancer Occurrence

  2010cites this paper
• Effect of MDR1 gene promoter methylation in patients with ulcerative colitis.

  2009cites this paper
• Promoter methylation of glutathione S‐transferase π1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression

  2009cites this paper
• Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis.

  2009cites this paper
• Caractérisation du transport transépithélial de cadmium dans les cellules intestinales humaines TC7 cultivées sur filtres

  2009cites this paper
• Multidrug Resistance Mediated by MDR-ABC Transporters

  2009cites this paper
• Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

  2008cites this paper
• Methylation status of breast cancer resistance protein detected by methylation‐specific polymerase chain reaction analysis is correlated inversely with its expression in drug‐resistant lung cancer cells

  2008cites this paper
• Epigenetics in bladder cancer

  2008cites this paper
• Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.

  2008cites this paper
• Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia.

  2008cites this paper
• Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells

  2008cites this paper
• The establishment of two paclitaxel‐resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines

  2007cites this paper
• MOLECULAR GENETIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS ANTIRETROVIRAL THERAPY RESPONSE IN SOUTH AFRICA - A PHARMACOGENETICS STUDY

  2007cites this paper
• Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells

  2007cites this paper
• MDR1 Hypermethylation contributes to the progression of neuroblastoma

  2007cites this paper
• The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.

  2007cites this paper
• Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine

  2006cites this paper
• Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers.

  2006cites this paper
• Knowledge of epigenetic influence for prostate cancer therapy.

  2006cites this paper
• Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol)

  2006cites this paper
• Characterization of Gene Rearrangements Leading to Activation of MDR-1*>

  2006cites this paper
• Regulation of multidrug resistance by pro-inflammatory cytokines.

  2006cites this paper
• Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.

  2006cites this paper
• Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells.

  2006cites this paper
• Diagnostic and Prognostic Information in Prostate Cancer with the Help of a Small Set of Hypermethylated Gene Loci

  2005cites this paper